{"id":764,"date":"2018-01-24T08:54:48","date_gmt":"2018-01-24T08:54:48","guid":{"rendered":"http:\/\/militra.signus.lt\/?p=764"},"modified":"2026-07-21T16:05:34","modified_gmt":"2026-07-21T13:05:34","slug":"kas-antras-uzsikrete-ziv-per-narkotikus-2017-m-duomenys","status":"publish","type":"post","link":"https:\/\/militra.lt\/en\/kas-antras-uzsikrete-ziv-per-narkotikus-2017-m-duomenys\/","title":{"rendered":"Kas antras u\u017esikr\u0117t\u0117 \u017dIV per narkotikus &#8211; 2017 m. duomenys"},"content":{"rendered":"<h3 class=\"page-title\">Kas antras u\u017esikr\u0117t\u0117 \u017dIV per narkotikus &#8211; 2017 m. duomenys<\/h3>\n<div class=\"page-block\">\n<div>\n<p>U\u017ekre\u010diam\u0173j\u0173 lig\u0173 ir AIDS centro duomenimis, pernai kas antras (51,7 proc.) \u017dIV infekcija u\u017esikr\u0117t\u0117 vartodamas \u0161virk\u0161\u010diamuosius narkotikus. Nauj\u0173 \u017dIV atvej\u0173 tarp vyr\u0173 nustatyta 5 kartus daugiau nei tarp moter\u0173 &#8211; atitinkamai 220 ir 43. Daugiausiai u\u017esikr\u0117tusi\u0173 \u017dIV vyr\u0173 i\u0161ai\u0161kinta Alytaus pataisos namuose (56) bei dar 41 atvejis kitose \u012fkalinimo \u012fstaigose. Daugumos (vir\u0161 80 proc.) \u012fkalinimo staigose nustatyt\u0173 nauj\u0173 \u017dIV atvej\u0173 pagrindinis infekcijos perdavimo b\u016bdas &#8211; narkotik\u0173 vartojimas.<\/p>\n<p>Pagal u\u017esikr\u0117timo b\u016bd\u0105 tre\u010ddalis (30,2 proc.) pernai u\u017eregistruot\u0173 asmen\u0173 u\u017esikr\u0117t\u0117 \u017dIV per  lytinius santykius &#8211; 64 asmenys (24,3 proc.) u\u017esikr\u0117t\u0117 heteroseksuali\u0173, 18 (6,8 proc.) \u2013 homoseksuali\u0173 santyki\u0173 metu. 44 asmen\u0173 (16,7 proc.) u\u017esikr\u0117timo b\u016bdas nenustatytas. U\u017eregistruotas vienas \u017dIV perdavimo i\u0161 motinos vaikui atvejis. I\u0161 viso pernai per \u0161virk\u0161\u010diam\u0173j\u0173 narkotik\u0173 vartojim\u0105 u\u017esikr\u0117t\u0117 \u017dIV 136 asmenys.<\/p>\n<p>&#8222;Tai, kad \u017dIV infekcija pastaruosius pora met\u0173 v\u0117l spar\u010diau prad\u0117jo plisti tarp narkotikus vartojan\u010di\u0173 asmen\u0173, rodo, jog narkomanijos prevencijos intervencijos \u0161alyje yra nepakankamos. \u017dIV infekcija, kaip lakmuso popier\u0117lis, parodantis rizikos vietas, kur svarbu sustiprinti prevencines paj\u0117gas&#8221;, &#8211; pa\u017eym\u0117jo U\u017ekre\u010diam\u0173j\u0173 lig\u0173 ir AIDS centro vadovas, medicinos moksl\u0173 daktaras, profesorius Saulius \u010caplinskas.<\/p>\n<p>I\u0161 viso, iki \u0161i\u0173 met\u0173 sausio 1 d., Lietuvoje \u017dIV infekcija diagnozuota 3012 asmen\u0173. Daugiausiai u\u017esikr\u0117tusi\u0173j\u0173 \u017dIV registruota 25 &#8211; 44 met\u0173 am\u017eiaus grup\u0117je; daugiausiai (59 proc.) vis\u0173 registruot\u0173 u\u017esikr\u0117tusi\u0173j\u0173 \u017dIV, \u0161ia infekcija u\u017esikr\u0117t\u0117 per \u0161virk\u0161\u010diam\u0173j\u0173 narkotik\u0173 vartojim\u0105. Kas penktas \u017dIV u\u017esikr\u0117t\u0119s asmuo Lietuvoje susirgo paskutine \u017dIV ligos stadija &#8211; AIDS ir kas septintas asmuo, kuriam diagnozuota \u017dIV infekcija Lietuvoje, yra jau mir\u0119s nuo \u012fvairi\u0173 prie\u017eas\u010di\u0173, \u012fskaitant AIDS.<\/p>\n<p>\u012eveikti AIDS epidemij\u0105 iki 2030 met\u0173 &#8211; tai Jungtini\u0173 Taut\u0173 AIDS strategijoje i\u0161keltas  globalus tikslas. \u0160\u012f tiksl\u0105 pasauliniu mastu numatoma pasiekti \u012fgyvendinant artimesnius &#8211; iki 2020 m.- u\u017edavinius: 90-90-90, kas rei\u0161kia siekti, kad 90 proc. su \u017dIV gyvenan\u010di\u0173 asmen\u0173 \u017einot\u0173, kad yra u\u017esikr\u0117t\u0119 \u017dIV, 90 proc. j\u0173 b\u016bt\u0173 skiriama ART ir 90 proc. ART gaunan\u010di\u0173 asmen\u0173 b\u016bt\u0173 pasiekta ma\u017ea virus\u0173 koncentracija. ULAC gydytoj\u0173 atlikto vertinimo duomenimis, \u0161i\u0173 u\u017edavini\u0173 pasiekimo rodikliai Lietuvoje 2016 m. atitinkamai buvo 82\/30\/82.<\/p>\n<p>Vertinant \u0161iuos rodiklius, akivaizdu, kad \u017dIV infekcijos gydymo tiek organizacinis tiek komunikacinis prieinamumas yra nepakankami ir tai artimiausi i\u0161\u0161\u016bkiai \u0161alyje siekiant tolesn\u0117s \u017dIV atsako pa\u017eangos.<\/p>\n<\/div>\n<pre>Parengta Pagal ULAC informacij\u0105<\/pre>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Kas antras u\u017esikr\u0117t\u0117 \u017dIV per narkotikus &#8211; 2017 m. duomenys U\u017ekre\u010diam\u0173j\u0173 lig\u0173 ir AIDS centro duomenimis, pernai kas antras (51,7 proc.) \u017dIV infekcija u\u017esikr\u0117t\u0117 vartodamas \u0161virk\u0161\u010diamuosius narkotikus. Nauj\u0173 \u017dIV atvej\u0173 tarp vyr\u0173 nustatyta 5 kartus daugiau nei tarp moter\u0173 &#8211; atitinkamai 220 ir 43. Daugiausiai u\u017esikr\u0117tusi\u0173 \u017dIV vyr\u0173 i\u0161ai\u0161kinta Alytaus pataisos namuose (56) bei dar [&hellip;]<\/p>\n","protected":false},"author":78,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"slim_seo":{"title":"Kas antras u\u017esikr\u0117t\u0117 \u017dIV per narkotikus - 2017 m. duomenys - Militra.lt","description":"Kas antras u\u017esikr\u0117t\u0117 \u017dIV per narkotikus - 2017 m. duomenys U\u017ekre\u010diam\u0173j\u0173 lig\u0173 ir AIDS centro duomenimis, pernai kas antras (51,7 proc.) \u017dIV infekcija u\u017esikr\u0117t\u0117 v"},"_glsr_average":0,"_glsr_ranking":0,"_glsr_reviews":0,"_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[45],"tags":[],"class_list":["post-764","post","type-post","status-publish","format-standard","hentry","category-naujienos"],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":8}},"acf":[],"_links":{"self":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts\/764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/users\/78"}],"replies":[{"embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/comments?post=764"}],"version-history":[{"count":1,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts\/764\/revisions"}],"predecessor-version":[{"id":271944,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/posts\/764\/revisions\/271944"}],"wp:attachment":[{"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/media?parent=764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/categories?post=764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/militra.lt\/en\/wp-json\/wp\/v2\/tags?post=764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}